Migration, Distribution, and Safety Evaluation of Specific Phenotypic and Functional Mouse Spleen-Derived Invariant Natural Killer T2 Cells after Adoptive Infusion

Figure 1

The rates of iNKT cells and proportion of iNKT cell subsets. (a–c) The frequency of iNKT cells and the proportion of iNKT subsets in the spleen of normal mice. (d) The frequency of iNKT cells before purification and three days after injection α-GalCer. (e, f) The proportion of iNKT cell subsets before purification and three days after injection of α-GalCer. (g) The frequency of iNKT cells after purification and three days after injection of α-GalCer. (h, i) The proportion of iNKT cell subsets after purification and three days after injection of α-GalCer.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)